Myasthenia And HIV Infection: An Unusual Combination, One Case Report In Abidjan, Ivory Coast

Authors

  • Nancy Essoin-De Souza Felix Houphouet Boigny University of Abidjan , Neurology Department, Treichville University Hospital, Ivory Coast
  • Cedric Agbo-Panzo Medical Sciences Training and Research Unit, Félix Houphouët Boigny University, BP V 166, Abidjan, Ivory Coast , Neurology Department, Cocody University Hospital, BP V13 Abidjan 01, Ivory Coast
  • Samuel Yeo Neurology Department, Treichville University Hospital, 01 BP V03 Abidjan 01, Ivory Coast , Medical Sciences Training and Research Unit, Félix Houphouët Boigny University, BP V 166, Abidjan, Ivory Coast
  • Yves Broh Neurology Department, Treichville University Hospital, 01 BP V03 Abidjan 01, Ivory Coast
  • Idocile Maku Neurology Department, Cocody University Hospital, BP V13 Abidjan 01, Ivory Coast
  • Mody Koné Medical Sciences Training and Research Unit, Félix Houphouët Boigny University, BP V 166, Abidjan, Ivory Coast
  • Stéphane Abbe Neurology Department, Treichville University Hospital, 01 BP V03 Abidjan 01, Ivory Coast , Medical Sciences Training and Research Unit, Félix Houphouët Boigny University, BP V 166, Abidjan, Ivory Coast
  • Roxane Buseize Neurology Department, Treichville University Hospital, 01 BP V03 Abidjan 01, Ivory Coast , Medical Sciences Training and Research Unit, Félix Houphouët Boigny University, BP V 166, Abidjan, Ivory Coast
  • Ismaila Diakite Neurology Department, Treichville University Hospital, 01 BP V03 Abidjan 01, Ivory Coast , Neurology Department, Cocody University Hospital, BP V13 Abidjan 01, Ivory Coast
  • Léonard Kouassi Neurology Department, Treichville University Hospital, 01 BP V03 Abidjan 01, Ivory Coast , Medical Sciences Training and Research Unit, Félix Houphouët Boigny University, BP V 166, Abidjan, Ivory Coast
  • Mariam Doumbia-Ouattara Neurology Department, Treichville University Hospital, 01 BP V03 Abidjan 01, Ivory Coast , Neurology Department, Cocody University Hospital, BP V13 Abidjan 01, Ivory Coast

Keywords:

Myasthenia gravis, HIV, Immunosuppressive therapy, Antiretroviral treatment, Ivory Coast

Abstract

Introduction: The co-occurrence of autoimmune myasthenia gravis and HIV infection is poorly documented. Existing cases of combination myasthenia gravis and HIV are often associated with immune reconstitution inflammatory syndrome (IRIS), whereas the onset of myasthenia gravis prior to HIV diagnosis is exceptional. Observation: We report the case of a 43-year-old woman with seronegative generalized myasthenia gravis since 2002, 23 years before presentation, diagnosed with HIV-1 infection in 2009, 16 years before presentation. She was virologically stable on triple antiretroviral therapy (CD4 = 993/mm³, undetectable viral load). Electroneuromyography showed a 25% decremental response on repetitive nerve stimulation. Anti-AChR antibodies were negative; MuSK and LRP4 were not tested. During a myasthenic crisis with respiratory distress and muscarinic features, pyridostigmine was stopped and resuscitation measures were undertaken. Subsequent corticosteroid and azathioprine therapy led to marked improvement (Garches score 55 → 85 after 8 months). Conclusion: This rare case of myasthenia preceding HIV diagnosis illustrates an association independent of IRIS. It suggests that immunosuppressive therapy can be used safely in well-controlled HIV infection under close virological and immunological monitoring within a multidisciplinary framework.

Downloads

Download data is not yet available.

References

Bubuioc AM, Kudebayeva A, Turuspekova S, Lisnic V, Leone MA. The epidemiology of myasthenia gravis. J Med Life. 2021;14(1):7-16. doi:10.25122/jml-2020-0145.

Gilhus NE, Verschuuren JJ. Myasthenia gravis: subgroup classification and therapeutic strategies. Lancet Neurol. 2015;14(10):1023-36. doi:10.1016/S1474-4422(15)00141-0.

Heckmann JM, Marais S. Management issues in myasthenia gravis patients living with HIV: a case series and literature review. Front Neurol. 2020; 11:775. doi:10.3389/fneur.2020.00775.

Sherpa M, Metai RK, Kumar V, Hirachan T, Ahmed KU, Atkinson SJ. Comorbid human immunodeficiency virus (HIV) and muscle-specific kinase (MuSK) myasthenia gravis: a case report and literature review. Am J Case Rep. 2017;18:427-30. doi:10.12659/AJCR.902831.

Ragunathan K, Pathak B, Dahal K. MuSK myasthenia gravis as a manifestation of immune restoration disease in an HIV-positive patient. J Neurol. 2015;262(3):777-8. doi:10.1007/s00415-014-7582-5.

Choudhary A, Kumar N, Gupta S, Anand R, Verma R, Sharma P, et al. Myasthenia gravis in HIV-infected patients: report of two cases and review of the literature. J Clin Neuromuscul Dis. 2014;15(4):159-64. doi:10.1097/CND.0000000000000041.

O’Connor KC, Sriram S, Vincent A. Autoimmune neuromuscular disorders in HIV-positive patients: emerging evidence. Curr Opin Neurol. 2019;32(5):775-85. doi:10.1097/WCO.0000000000000740.

Wirtz PW. Dysphagia and respiratory failure in an HIV patient: MuSK myasthenia gravis. Acta Neurol Belg. 2020;120(6):1483-4. doi:10.1007/s13760-020-01461-9.

Gilhus NE, Tzartos S, Evoli A, Palace J, Burns TM, Verschuuren JJ. Myasthenia gravis. Nat Rev Dis Primers. 2019;5:30. doi:10.1038/s41572-019-0085-1.

Farrugia ME, Goodfellow JA. A practical approach to managing patients with myasthenia gravis: opinions and a review of the literature. Front Neurol. 2020;11:604. doi:10.3389/fneur.2020.00604.

The co-occurrence of autoimmune myasthenia gravis and HIV infection is poorly documented. Existing cases of combination myasthenia gravis and HIV are often associated with immune reconstitution inflammatory syndrome (IRIS), whereas the onset of myasthenia gravis prior to HIV diagnosis is exceptional

Downloads

Published

01-01-2026

Issue

Section

Case reports

Categories

How to Cite

1.
Myasthenia And HIV Infection: An Unusual Combination, One Case Report In Abidjan, Ivory Coast. EAJNS [Internet]. 2026 Jan. 1 [cited 2026 Feb. 9];5(1):59-61. Available from: http://www.theeajns.org/index.php/eajns/article/view/355